1. Home
  2. VNDA vs HRZN Comparison

VNDA vs HRZN Comparison

Compare VNDA & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$3.99

Market Cap

231.0M

Sector

Health Care

ML Signal

N/A

Logo Horizon Technology Finance Corporation

HRZN

Horizon Technology Finance Corporation

N/A

Current Price

$3.73

Market Cap

265.5M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VNDA
HRZN
Founded
2002
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance/Investors Services
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
231.0M
265.5M
IPO Year
2005
2010

Fundamental Metrics

Financial Performance
Metric
VNDA
HRZN
Price
$3.99
$3.73
Analyst Decision
Strong Buy
Hold
Analyst Count
5
6
Target Price
★ $11.50
$4.71
AVG Volume (30 Days)
★ 1.3M
507.8K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
★ 19.15%
EPS Growth
N/A
★ 62.50
EPS
N/A
★ N/A
Revenue
★ $216,105,000.00
N/A
Revenue This Year
$12.05
$0.10
Revenue Next Year
$30.61
$17.78
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 8.72
N/A
52 Week Low
$3.57
$3.70
52 Week High
$9.91
$6.78

Technical Indicators

Market Signals
Indicator
VNDA
HRZN
Relative Strength Index (RSI) 43.50 31.65
Support Level $3.57 N/A
Resistance Level $5.49 $4.75
Average True Range (ATR) 0.28 0.17
MACD 0.05 -0.01
Stochastic Oscillator 34.42 12.44

Price Performance

Historical Comparison
VNDA
HRZN

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

About HRZN Horizon Technology Finance Corporation

Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.

Share on Social Networks: